Shaokun Shu

2.5k total citations
18 papers, 575 citations indexed

About

Shaokun Shu is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Shaokun Shu has authored 18 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Shaokun Shu's work include CAR-T cell therapy research (3 papers), Protein Degradation and Inhibitors (3 papers) and Single-cell and spatial transcriptomics (2 papers). Shaokun Shu is often cited by papers focused on CAR-T cell therapy research (3 papers), Protein Degradation and Inhibitors (3 papers) and Single-cell and spatial transcriptomics (2 papers). Shaokun Shu collaborates with scholars based in China, United States and Ethiopia. Shaokun Shu's co-authors include Kornélia Polyák, Mei Feng, Yisheng Pan, Ruirui Kong, Lu‐Hai Wang, George Z. Cheng, Weizhou Zhang, Sungman Park, Lili He and William Kong and has published in prestigious journals such as Nature Communications, JNCI Journal of the National Cancer Institute and Nature Methods.

In The Last Decade

Shaokun Shu

17 papers receiving 565 citations

Peers

Shaokun Shu

ONCOL

IMMUN

PFM

Beate Alinger Austria

Sylvia Mahara Singapore

Magali Castells France

Yingqiu Y. Liu United States

Alice Agliano Spain

Anja Deutzmann United States

Takafumi Kuroda Japan

Mohamad A. Salkeni United States

Shane W. O’Brien United States

Timothy A. Yap United Kingdom

Beate Alinger Austria

Shaokun Shu

490 ×1.5

192 ×0.9

ONCOL

152 ×0.9

75 ×0.7

IMMUN

79 ×1.2

PFM

Citations per year, relative to Shaokun Shu Shaokun Shu (= 1×) peers Beate Alinger

Countries citing papers authored by Shaokun Shu

Since Specialization

Citations

This map shows the geographic impact of Shaokun Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaokun Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaokun Shu more than expected).

Fields of papers citing papers by Shaokun Shu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaokun Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaokun Shu. The network helps show where Shaokun Shu may publish in the future.

Co-authorship network of co-authors of Shaokun Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Shaokun Shu. A scholar is included among the top collaborators of Shaokun Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaokun Shu. Shaokun Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Liu, Yaxi, et al.. (2024). Single-cell EpiChem jointly measures drug–chromatin binding and multimodal epigenome. Nature Methods. 21(9). 1624–1633. 5 indexed citations

Li, Yun, Zhaojun Zhang, Qifei Wang, et al.. (2023). FIPRESCI: droplet microfluidics based combinatorial indexing for massive-scale 5′-end single-cell RNA sequencing. Genome biology. 24(1). 70–70. 12 indexed citations

Alečković, Maša, Zheqi Li, Xintao Qiu, et al.. (2023). Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer. Molecular Cancer Therapeutics. 22(11). 1304–1318. 6 indexed citations

Tu, Bo, Haojie Wang, Haimeng Li, et al.. (2023). The Lin28b/Wnt5a axis drives pancreas cancer through crosstalk between cancer associated fibroblasts and tumor epithelium. Nature Communications. 14(1). 6885–6885. 12 indexed citations

An, Ni, Jie Zhang, Fan Mo, et al.. (2023). De novo genes with an lncRNA origin encode unique human brain developmental functionality. Nature Ecology & Evolution. 7(2). 264–278. 35 indexed citations

Li, Miaomiao, Yingying Ye, Lan Mi, et al.. (2022). Anti‐CD47 immunotherapy in combination with BCL‐2 inhibitor to enhance anti‐tumor activity in B‐cell lymphoma. Hematological Oncology. 40(4). 596–608. 14 indexed citations

Ye, Yingying, Ning Ding, Lan Mi, et al.. (2021). Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas. Experimental Hematology and Oncology. 10(1). 9–9. 28 indexed citations

Liu, Weiping, Lan Mi, Shaokun Shu, et al.. (2021). THE CD19/CD3 BISPECIFIC ANTIBODY WORK EFFECTIVELY AS ADJUNCT WITH IBRUTINIB ON THE TREATMENT OF B‐CELL LYMPHOMA. Hematological Oncology. 39(S2). 1 indexed citations

Feng, Mei, Yisheng Pan, Ruirui Kong, & Shaokun Shu. (2020). Therapy of Primary Liver Cancer. The Innovation. 1(2). 100032–100032. 73 indexed citations

10.

Marusyk, Andriy, Doris P. Tabassum, Michalina Janiszewska, et al.. (2016). Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes. Cancer Research. 76(22). 6495–6506. 96 indexed citations

11.

Shu, Shaokun & Kornélia Polyák. (2016). BET Bromodomain Proteins as Cancer Therapeutic Targets. Cold Spring Harbor Symposia on Quantitative Biology. 81. 123–129. 54 indexed citations

12.

Almendro, Vanessa, Shaokun Shu, Guillermo Peluffo, et al.. (2012). Abstract P4-06-01: JAK2/STAT3 activity in inflammatory breast cancer supports the investigation of JAK2 therapeutic targeting. Cancer Research. 72(24_Supplement). P4–6. 4 indexed citations

13.

Shu, Shaokun. (2010). Molecular Mechanism of AGC Kinases in Human Malignant. Digital Commons - University of South Florida (University of South Florida). 1 indexed citations

14.

Shu, Shaokun, Mei Sun, Donghwa Kim, & Jin Cheng. (2010). Abstract 3836: Regulation of class III PI3K by class I PI3K/Akt inhibits autophagy through phosphorylation of UVRAG. Cancer Research. 70(8_Supplement). 3836–3836. 1 indexed citations

15.

Guo, Jianping, Shaokun Shu, Lili He, et al.. (2009). Deregulation of IKBKE Is Associated with Tumor Progression, Poor Prognosis, and Cisplatin Resistance in Ovarian Cancer. American Journal Of Pathology. 175(1). 324–333. 74 indexed citations

16.

Wang, Lu‐Hai, George Z. Cheng, Sungman Park, et al.. (2008). Advances of AKT Pathway in Human Oncogenesis and as a Target for Anti-Cancer Drug Discovery. Current Cancer Drug Targets. 8(1). 2–6. 99 indexed citations

17.

Zhao, Caifeng, Bingran Zhao, Yan Ren, et al.. (2007). Seeking Transformation Markers: An Analysis of Differential Tissue Proteomes on the Rice Germplasm Generated from Transformation of Echinochloa crusgalli Genomic DNA. Journal of Proteome Research. 6(4). 1354–1363. 7 indexed citations

18.

Taback, Bret, Steven O’Day, Peter D. Boasberg, et al.. (2004). Circulating DNA Microsatellites: Molecular Determinants of Response to Biochemotherapy in Patients With Metastatic Melanoma. JNCI Journal of the National Cancer Institute. 96(2). 152–156. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact